Industry Overview - The Zacks Tobacco industry is facing significant challenges due to persistent pressure on cigarette volumes, driven by inflation, changing consumer preferences, and stringent regulations [1][4] - Traditional cigarette consumption is declining due to rising health awareness and tighter restrictions on tobacco sales and marketing [1][4] - The industry includes companies that manufacture cigarettes and various tobacco and nicotine-based products, with many firms also producing reduced-risk products (RRPs) like e-cigarettes and heated tobacco [3] Current Trends - Persistent pressure on cigarette volumes is attributed to inflation and economic factors that have altered consumer spending behavior, alongside regulatory restrictions impacting sales [4] - Elevated costs from global inflation affecting key inputs such as tobacco leaf, energy, and labor are adding to margin pressures, despite companies attempting to offset these through pricing actions [5] - The rising popularity of smoke-free options, including heated tobacco and vapor products, is reshaping the industry, with major companies investing in these categories to align with consumer preferences [6] Company Performance - Leading companies like Philip Morris International, British American Tobacco, and Altria Group are focusing on smoke-free alternatives to demonstrate resilience in a challenging environment [2] - Philip Morris is recognized for its transformative shift towards smoke-free products, with flagship offerings like IQOS and ZYN gaining traction [17] - British American Tobacco is advancing its transition through a diversified strategy, with brands like Vuse and glo gaining market share [21] - Altria is evolving its business model by prioritizing reduced-risk products and leveraging its strong brand portfolio, including Marlboro [25] Financial Metrics - The Zacks Tobacco industry currently holds a Zacks Industry Rank of 218, placing it in the bottom 10% of over 243 Zacks industries, indicating dull near-term prospects [7][8] - The industry has gained 16.1% over the past year, underperforming the S&P 500's growth of 18.7% but outperforming the broader Zacks Consumer Staples sector, which declined by 4.4% [10] - The industry is trading at a forward 12-month price-to-earnings (P/E) ratio of 14.61X, compared to the S&P 500's 20.8X and the sector's 16.39X [13] Earnings Estimates - The Zacks Consensus Estimate for Philip Morris's 2026 and 2027 earnings per share (EPS) remains unchanged at $8.49 and $9.30, respectively [18] - For British American Tobacco, the EPS estimates for 2026 and 2027 have decreased slightly to $4.87 and $5.29, respectively [22] - Altria's EPS estimates for 2026 and 2027 remain unchanged at $5.61 and $5.78, respectively [26]

Core Insights - Philip Morris International (PM) reported full-year 2025 revenue of $40.6 billion, with smoke-free products contributing approximately $17 billion, while British American Tobacco (BTI) reported Q4 2025 EPS of $2.55, exceeding estimates, and raised its 2026 quarterly dividend to $0.835 from $0.749 [1] - PM's IQOS maintained a 76% global market share in heated tobacco, and ZYN saw a 37% growth in shipments in the U.S. with 794 million cans shipped [1] - PM trades at a trailing P/E of 23x, reflecting consistent earnings and growth in smoke-free products, while BTI trades at 13x, offering a higher yield but with a more volatile earnings history [1] Financial Performance - PM's adjusted operating income margin expanded to 40.4%, with management guiding for adjusted diluted EPS of $8.38 to $8.53 in 2026, indicating an expected growth of 11% to 13% [1] - BTI's Q4 2025 EPS of $2.55 beat the estimate of $2.51, but its smoke-free brands are growing at a slower pace compared to PM [1] - PM's revenue growth is driven by its smoke-free segment, while BTI's earnings history shows inconsistencies, including a -$0.66 EPS in Q4 2024 and a significant miss in Q2 2025 [1] Investment Considerations - PM is positioned as a growth stock with a focus on smoke-free transformation, appealing to investors seeking capital appreciation alongside dividend growth [1] - BTI offers a higher dividend yield of 5.64% compared to PM's 3.26%, making it attractive for income-focused investors despite its lower growth narrative [1] - The valuation gap between PM and BTI reflects differing investment profiles, with PM commanding a premium due to its consistent earnings performance and growth potential [1]

Summary of British American Tobacco (BAT) 2026 Conference Call Company Overview - **Company**: British American Tobacco (NYSE: BTI) - **Event**: 2026 Conference Call held on February 18, 2026 - **Key Speakers**: Tadeu Marroco (CEO), David Waterfield (President of Reynolds American) Core Industry Insights - **Transformation Goal**: BAT aims to become predominantly smokeless by 2035, focusing on a smoke-free future while maintaining organic growth and shareholder returns [2][3] - **Market Growth**: The nicotine industry is projected to grow at a 4% CAGR over the next five years, driven by double-digit growth in new categories like nicotine pouches, which are expected to nearly triple in revenue by 2030 [3][4] - **Consumer Behavior**: There is a significant shift as smokers transition to less risky alternatives, with polyuse (using multiple nicotine products) doubling over the last five years [4][5] Financial Performance - **Cash Flow**: BAT has generated strong free cash flow, allowing for substantial shareholder returns through dividends and share buybacks [1] - **Revenue Growth Targets**: BAT aims for 3%-5% revenue growth, 4%-6% adjusted profit from operations growth, and 5%-8% adjusted diluted EPS growth in the midterm [25] Product Categories - **Nicotine Pouches**: Fastest-growing category, with VELO being a leading brand. VELO's consumer numbers, volume, and revenue have tripled over the last three years [9][11] - **Vapor Products**: Vuse is the global leader with a 39% market share, and the category is expected to grow significantly as regulatory environments improve [13][14] - **Heated Products**: The glo product line is positioned in a growing market, with a focus on premium segments [15][16] Regulatory Environment - **Regulatory Progress**: There are now 24 countries with regulatory frameworks for nicotine pouches, up from 4 in 2022. The FDA has initiated a pilot program to expedite the approval process for nicotine pouches [12][38] - **Enforcement Actions**: Increased enforcement against illegal products is crucial for the vapor market, with significant progress noted in 2025 [37][38] U.S. Market Focus - **U.S. Strategy**: The U.S. is a cornerstone of BAT's strategy, with Reynolds American positioned to capitalize on the evolving market. The U.S. nicotine revenue pool is projected to grow above a 4% CAGR through 2030 [26][28] - **Investment Commitment**: BAT is committing GBP 2.5 billion by 2030 to support U.S. growth, which is expected to create over 2,000 jobs [30][31] Competitive Positioning - **Market Leadership**: Reynolds is the number one choice for adult nicotine consumers, with nearly 22 million users. The company has seen growth in all product categories, particularly in smokeless and new categories [32][33] - **Value Share Growth**: Reynolds has increased its total nicotine volume share by over 100 basis points from December 2024 to December 2025, with significant contributions from smokeless categories [33][34] Conclusion - **Sustainable Value Creation**: BAT is focused on delivering sustainable value while preparing for future growth through a balanced portfolio of combustibles and new categories [42][43] - **Future Outlook**: The company is well-positioned to lead in the U.S. nicotine market, leveraging its multi-category portfolio and commitment to innovation and regulatory engagement [43][44]

Core Insights - Altria Group, Inc. is committed to transitioning towards a smoke-free future, with a focus on its oral tobacco portfolio, particularly the on! nicotine pouch brand, which has shown significant growth in shipment volumes and market share [1][2][9] - The company's oral tobacco revenues increased by 0.5% to $654 million in Q1 2025, driven by pricing power despite macroeconomic challenges [2] - Altria faces challenges in the vapor segment, particularly after regulatory issues led to the discontinuation of its NJOY ACE product, but plans to introduce compliant alternatives [3][4] Oral Tobacco Performance - The on! nicotine pouch brand's shipment volumes rose 18% year-over-year, exceeding 39 million cans, and its market share in the oral tobacco category increased by 1.8 percentage points to 8.8% [1][9] - The nicotine pouch market share for on! reached 17.9%, indicating strong consumer loyalty and brand strength despite retail price increases [1] Vapor Segment Challenges - Regulatory setbacks have impacted Altria's vapor products, leading to the discontinuation of NJOY ACE, but the company is working on launching new compliant products to regain market share [3][4] Competitive Landscape - Altria competes with Philip Morris International and British American Tobacco in the smoke-free category, both of which are also focusing on reduced-risk products [5][6][7] - Philip Morris reported a 20.4% increase in net revenues and a 33.1% rise in smoke-free gross profit, with significant growth in its ZYN and VEEV products [6] - British American Tobacco aims for 50 million consumers by 2030 and reported a 2.5% increase in New Category revenues in 2024 [7] Financial Performance and Valuation - Altria's stock has gained 12.5% year-to-date, while the industry has grown by 37.7% [8] - The company trades at a forward price-to-earnings ratio of 10.76X, below the industry average of 15.36X [11] - Earnings estimates for 2025 and 2026 suggest year-over-year growth of 4.9% and 3.3%, respectively, with recent upward revisions [12]

Core Insights - Altria Group, Inc. is facing significant challenges as it transitions towards smoke-free alternatives, primarily due to the rise of illicit flavored disposable e-vapor products that are reshaping the U.S. nicotine market [1][3]. Company Performance - In Q1 2025, Altria reported that the adult e-vapor user base in the U.S. has exceeded 20 million, with a year-over-year increase of over 2.6 million users, largely driven by disposable e-vapor products which gained nearly 4 million new users, reaching around 14 million [2]. - Altria estimates that over 60% of the expanding e-vapor market is now dominated by unauthorized, non-compliant products, which poses a significant challenge to its smoke-free revenue growth [2][10]. Market Dynamics - The surge in illicit e-vapor products is a major obstacle for Altria's smoke-free revenue growth, dampening its progress despite an increasing market presence [3]. - The company is collaborating with regulators to address enforcement gaps, but the ongoing availability of illicit products remains a significant barrier [4]. Competitive Landscape - Major tobacco companies like Philip Morris International and British American Tobacco are also accelerating their transition towards smoke-free alternatives, investing in reduced-risk products to adapt to changing consumer preferences and regulatory landscapes [6]. - Philip Morris reported that smoke-free offerings contributed 44% of its gross profit in Q1 2025, with a 20.4% rise in net revenues and a 33.1% increase in smoke-free gross profit [7]. - British American Tobacco aims to reach 50 million consumers by 2030, with its smokeless user base reaching 29.1 million in 2024 [8]. Financial Metrics - Altria's shares have gained 14.4% year-to-date, compared to the industry's growth of 40.8% [9]. - The company trades at a forward price-to-earnings ratio of 10.96X, below the industry average of 15.74X, with a forecasted EPS growth of 5.3% for 2025 [10][12]. - The Zacks Consensus Estimate for Altria's 2025 earnings implies a year-over-year growth of 5.3%, while the 2026 earnings estimate suggests an increase of almost 3% [13].

Core Insights - Philip Morris International Inc. (PM) is accelerating its transition from traditional tobacco to reduced-risk products, with smoke-free products accounting for 44% of total gross profit in Q1 2025, indicating significant progress towards becoming substantially smoke-free [1][8] Group 1: Product Performance - IQOS, PM's heat-not-burn device, achieved 9.4% growth in HTU-adjusted IMS, driven by strong performances in Japan and Europe [2] - ZYN, the oral nicotine pouch acquired from Swedish Match, saw shipments increase by 53% year-over-year to 202 million cans, with PM raising its 2025 shipment forecast to 800-840 million cans [2][8] Group 2: Financial Metrics - Smoke-free organic revenues increased by 20.4%, while gross profit rose by 33.1%, resulting in a gross margin exceeding 70%, significantly higher than combustible products [3][8] - PM's shares have increased by 52.3% year-to-date, outperforming the industry growth of 37% [7] Group 3: Competitive Landscape - Altria is expanding its smoke-free portfolio, with on! nicotine pouch shipments rising 18% year-over-year, contributing to $654 million in net revenues for its Oral Tobacco segment [5] - British American Tobacco aims for 50 million users of smoke-free products by 2030 and plans to derive 50% of revenues from this segment by 2035, with its New Category segment growing by 2.5% in 2024 [6] Group 4: Future Outlook - PM is well-positioned for future growth with strategic manufacturing investments in the U.S. and a multi-category strategy that includes e-vapor products [4] - The Zacks Consensus Estimate for PM's 2025 earnings suggests a year-over-year growth of 13.7%, with 2026 earnings expected to increase by 11.7% [12]

Core Insights - Altria Group, Inc. is progressing towards a smoke-free future, with its oral nicotine pouch brand on! being a significant growth driver as consumer preferences shift towards reduced-risk products [1][5] Group 1: Product Performance - In Q1 2025, on! shipment volume increased by 18% year over year, exceeding 39 million cans, and its retail market share in the oral tobacco category rose to 8.8%, a 1.8 share point increase [2][10] - Within the nicotine pouch segment, on! achieved a market share of 17.9%, gaining 0.5 points, indicating strong brand equity and consumer loyalty despite higher retail pricing [2][10] Group 2: Financial Performance - Altria's Oral Tobacco Products segment generated revenues of $654 million in Q1 2025, reflecting a 0.5% year-over-year increase, primarily driven by pricing strength [3][10] - The company's forward price-to-earnings ratio stands at 10.87X, which is below the industry average of 15.49X [12] Group 3: Strategic Initiatives - Altria has initiated the "Optimize & Accelerate" program, aiming for at least $600 million in cost savings over five years, focusing on enhancing efficiency and reinvesting in smoke-free innovations [4] - The company is positioning itself to lead in the smoke-free nicotine market, with on! becoming a cornerstone of its growth strategy [5] Group 4: Competitive Landscape - Key competitors in the smoke-free category include Philip Morris International and British American Tobacco, both of which are also shifting towards reduced-risk products [6][7][8] - Philip Morris reported that smoke-free products contributed 44% of its gross profit in Q1 2025, with significant growth in ZYN and VEEV shipments [7] - British American Tobacco aims to reach 50 million consumers by 2030, with its smokeless user base at 29.1 million in 2024 [8] Group 5: Earnings Estimates - The Zacks Consensus Estimate for Altria's 2025 earnings indicates a year-over-year growth of 4.5%, with 2026 estimates suggesting a 3.5% increase [13]

Core Insights - Philip Morris International Inc. (PM) is undergoing a significant transformation towards reduced-risk products, with smoke-free products contributing to 44% of total gross profit in Q1 2025 [1][9]. Group 1: Business Transformation - The company's multi-category strategy includes products like IQOS, ZYN, and VEEV, with IQOS showing a 9.4% HTU-adjusted IMS growth in Q1 despite regulatory challenges in Europe [2]. - ZYN's shipments in the U.S. surged by 53% year-over-year, reaching 202 million cans, prompting an increase in the full-year shipment forecast to 800-840 million cans [2][9]. - VEEV's shipment volumes more than doubled in the quarter, benefiting from expanded distribution in Europe [3]. Group 2: Financial Performance - The smoke-free segment experienced a 20.4% increase in net revenues and a 33.1% rise in gross profit, with gross margins exceeding 70% [3][9]. - PM's smoke-free products are now available in 95 markets, with nearly 38.6 million adult users globally [4][9]. Group 3: Competitive Landscape - Altria Group is focusing on building a smoke-free portfolio, with its on! nicotine pouch seeing an 18% year-over-year growth in shipments [6]. - British American Tobacco aims to reach 50 million consumers of smokeless products by 2030, with New Category revenues rising 2.5% in 2024 [7]. Group 4: Stock Performance and Valuation - PM's shares have increased by 51.4% year-to-date, outperforming the industry's growth of 38.5% [8]. - The company trades at a forward price-to-earnings ratio of 23.27X, above the industry's average of 15.46X [11]. - The Zacks Consensus Estimate for PM's 2025 earnings indicates a year-over-year growth of 13.7% [12].